Latest Technology News

ITM Isotope Technologies Munich SE and Radiopharm Theranostics have entered a strategic supply agreement for the critical radioisotope Lutetium-177, underpinning Radiopharm’s clinical development of targeted cancer therapies.

Vection Technologies has partnered with Laerdal Italia to integrate XR and AI solutions into healthcare simulation, aiming to generate $1.7 million in revenue over three years and expand across Europe.

Gentrack reported a solid 9.8% revenue increase to NZ$112 million in HY25, driven by recurring revenue growth and international expansion, while net profit after tax surged 34.7%. The company’s outlook remains optimistic as it targets FY25 revenue above NZ$230 million and deeper market penetration across Asia, Europe, and the Middle East.

Gentrack Group Limited reported a solid 9.8% revenue increase to NZ$112 million in the first half of FY25, powered by strong recurring revenue growth in utilities and a surge in its airports division, Veovo. Net profit after tax jumped 34.7%, supported by currency gains and a lower tax rate.

Gentrack Group Ltd reported a robust 9.8% revenue increase and a 34.7% jump in net profit for the first half of FY25, driven by strong recurring revenues and strategic global expansion.

Gentrack Group Limited reported a solid 9.8% revenue increase and a 34.7% jump in net profit for the first half of 2025, yet opted against paying an interim dividend.

Osteopore Limited has increased its capital raise by drawing down an additional A$500,000 on its Tranche 1 redeemable convertible notes, bringing total subscriptions to A$3.5 million. The funds will support ongoing operations and future growth initiatives.

Dicker Data announces the departure of co-founder David Dicker from CEO and Chairman roles, transitioning leadership to a seasoned executive team under co-founder Fiona Brown’s Executive Chairmanship.

Cynata Therapeutics confirms that the recent FDA orphan-drug exclusivity granted to Ryoncil® will not block approval of its CYP-001 therapy, highlighting key differences in drug composition and patient indications.

Australian Bond Exchange Holdings has completed a $683,180 private placement, issuing over 17 million shares to strengthen its financial position and support expansion and cost-cutting initiatives.

Simble Solutions Limited reported solid operational progress in 2024, expanding its customer base and partnerships across Australia and the UK while advancing into renewable energy development. The company’s strategic moves position it well for growth in the evolving energy and sustainability sector.

Hastings Technology Metals has entered a binding agreement with Wyloo to form a 60:40 joint venture on the Yangibana Rare Earths and Niobium Project, with Wyloo taking the lead on funding and management. This partnership aims to de-risk project development and accelerate progress toward final investment decision.